Co-Authors
This is a "connection" page, showing publications co-authored by Makoto Takeda and Shuetsu Fukushi.
Connection Strength
0.425
-
Performance Evaluation of Real-Time RT-PCR Assays for the Detection of Severe Acute Respiratory Syndrome Coronavirus-2 Developed by the National Institute of Infectious Diseases, Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):465-472.
Score: 0.233
-
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. Front Microbiol. 2021; 12:651403.
Score: 0.059
-
Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus. J Virol. 2019 03 15; 93(6).
Score: 0.051
-
Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen. Front Microbiol. 2016; 7:509.
Score: 0.042
-
Non Susceptibility of Neonatal and Adult Rats against the Middle East Respiratory Syndrome Coronavirus. Jpn J Infect Dis. 2016 Nov 22; 69(6):510-516.
Score: 0.041